The in vivo study where DCX was loaded into MSC-PLGA-b-PEG NPs showed that the MSC could improve the antitumor activity as it inhibits tumor growth more efficiently than DTX-PNPs at a lower dose of DCX. This evidence concerns the gene DCX and neoplasm.